Skip to main content
EJNMMI Research
Fig. 9 | EJNMMI Research

Fig. 9

From: Indium-111-labeled CD166-targeted peptide as a potential nuclear imaging agent for detecting colorectal cancer stem-like cells in a xenograft mouse model

Fig. 9

Tissue bio-distribution of 111In-DTPA-CD166tp-G18C in colorectal tumor xenograft mice. After 111In-DTPA-CD166tp-G18C and control groups (111In-DTPA, 111In-DTPA-G18C and 111In-DTPA-CD166tp-C) (148 MBq/kg/per mouse) intravenous injection for 2, 4, 24, and 48 h, CD166+HCT15 xenograft mice were sacrificed and obtained tumor, blood, and organs. The radioactivity of samples was detected by a gamma counter. Values are presented as the percentage of injected dose per gram organ (ID%/g). Data are presented as mean ± SD (n ≥ 3). *P < 0.05, versus control group

Back to article page